- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 68.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 76.5M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $270K |
| Capex | Q1 2026 · Mar 31, 2025 | $11K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.64M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2.93M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $26.59M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $25.35M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $44.86M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $51.04M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $23.79M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $28.02M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $23.79M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $28.02M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $52.67M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $58.22M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $57.93M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $63.62M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $9.07M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $6.98M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.27M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.23M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.37M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$6.39M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $22.29M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $19.04M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $23.8M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $18.99M |
| Revenue | Q1 2026 · Mar 31, 2026 | $46.09M |
| Revenue | Q1 2026 · Mar 31, 2025 | $38.02M |